Brain shrinkage needs closer scrutiny in trials of anti-amyloid drugs

Brain shrinkage, observed in trials of anti-amyloid antibodies used to treat Alzheimer's disease, needs closer scrutiny.

Related Keywords

Melbourne , Victoria , Australia , Scott Ayton , Eli Lilly , Drug Administration , Florey Institute , Creative Commons , Alzheimers Res Ther ,